Waypoint Bio
Checked
A company testing how treatments act within living tissue.
- Location
- NYC
- Funding
- $20M · Series AAnnounced ·
- Valuation
- Valuation undisclosed
What the figures mean
The company release is dated June 1, 2026; its press index groups the announcement under May 2026. The card uses the release date. The valuation is not disclosed.
Company team page lists its New York address. Reviewed October 9, 2026.
Founding team
Founders Xinchen WangDavid Phizicky
Sources
- Waypoint Bio — Series A release ↗
Company-issued announcement distributed by Business Wire.
- Waypoint Bio — press index ↗
Company archive and location.
- Waypoint — founding team and address ↗
Company identifies Xinchen Wang and David Phizicky as co-founders and lists its New York address. Reviewed October 9, 2026.
A dated snapshot of the public sources reviewed, not a live funding feed. Figures marked “reported” have not been independently confirmed with the company.